U.S. Physical Therapy (DB:UPH) - Stock Price, News & Analysis

UPH Stock Overview

Operates outpatient physical therapy clinics. More details

UPH fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	4/6
Past Performance	0/6
Financial Health	4/6
Dividends	3/6

Rewards

Trading at 45.7% below our estimate of its fair value

Earnings are forecast to grow 29.37% per year

Risk Analysis

Large one-off items impacting financial results

Profit margins (2.2%) are lower than last year (4.1%)

Dividend of 1.8% is not well covered by earnings

Significant insider selling over the past 3 months

U.S. Physical Therapy, Inc. Competitors

RHÖN-KLINIKUM

XTRA:RHK

€836.7m

M1 Kliniken

XTRA:M12

€307.1m

LIMES Schlosskliniken

XTRA:LIK

€99.7m

Gesundheitswelt Chiemgau

MUN:JTH

€24.4m

Price History & Performance

Summary of all time highs, changes and price drops for U.S. Physical Therapy
Historical stock prices
Current Share Price	US$89.50
52 Week High	US$104.00
52 Week Low	US$69.50
Beta	1.39
11 Month Change	19.33%
3 Month Change	20.13%
1 Year Change	11.88%
33 Year Change	13.29%
5 Year Change	-15.57%
Change since IPO	590.59%

Recent updates

Shareholder Returns

	UPH	DE Healthcare	DE Market
7D	7.2%	1.1%	0.2%
1Y	11.9%	16.5%	8.5%

Return vs Industry: UPH underperformed the German Healthcare industry which returned 16.5% over the past year.

Return vs Market: UPH exceeded the German Market which returned 8.5% over the past year.

Price Volatility

Is UPH's price volatile compared to industry and market?
UPH volatility
UPH Average Weekly Movement	5.5%
Healthcare Industry Average Movement	4.1%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.3%

Stable Share Price: UPH has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: UPH's weekly volatility (6%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1990	5,310	Chris Reading	www.usph.com

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

U.S. Physical Therapy, Inc. Fundamentals Summary

How do U.S. Physical Therapy's earnings and revenue compare to its market cap?
UPH fundamental statistics
Market cap	€1.42b
Earnings (TTM)	€13.54m
Revenue (TTM)	€613.69m

104.7x

P/E Ratio

2.3x

P/S Ratio

Is UPH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
UPH income statement (TTM)
Revenue	US$639.06m
Cost of Revenue	US$513.20m
Gross Profit	US$125.86m
Other Expenses	US$111.76m
Earnings	US$14.10m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.93
Gross Margin	19.69%
Net Profit Margin	2.21%
Debt/Equity Ratio	21.2%

How did UPH perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

187%

Payout Ratio

Does UPH pay a reliable dividends?

See UPH dividend history and benchmarks

When do you need to buy UPH by to receive an upcoming dividend?
U.S. Physical Therapy dividend dates
Ex Dividend Date	Nov 15 2024
Dividend Pay Date	Dec 06 2024
Days until Ex dividend	10 days
Days until Dividend pay date	11 days

Does UPH pay a reliable dividends?

See UPH dividend history and benchmarks

UPH Stock Overview

Rewards

Risk Analysis

U.S. Physical Therapy, Inc. Competitors

XTRA:RHK

€836.7m

XTRA:M12

€307.1m

XTRA:LIK

€99.7m

MUN:JTH

€24.4m

Price History & Performance

Recent News & Updates

President & COO recently sold €179k worth of stock

Third quarter dividend of US$0.44 announced

Third quarter 2024 earnings released: EPS: US$0.39 (vs US$0.51 in 3Q 2023)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

Recent updates

President & COO recently sold €179k worth of stock

Third quarter dividend of US$0.44 announced

Third quarter 2024 earnings released: EPS: US$0.39 (vs US$0.51 in 3Q 2023)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. announced delayed 10-Q filing

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

Now 21% undervalued after recent price drop

Chairman & CEO recently sold €196k worth of stock

Chief Operating Officer - East recently sold €242k worth of stock

First quarter dividend of US$0.44 announced

First quarter 2024 earnings released: EPS: US$0.54 (vs US$0.58 in 1Q 2023)

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Chief Operating Officer - West recently sold €253k worth of stock

Fourth quarter dividend of US$0.44 announced

New minor risk - Profit margin trend

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$1.99 (vs US$2.25 in FY 2022)

Now 21% undervalued

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Now 21% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: US$0.62 (vs US$0.72 in 3Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Chief Operating Officer - West recently sold €413k worth of stock

Second quarter 2023 earnings released: EPS: US$0.80 (vs US$0.87 in 2Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million.

U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million

U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million.

U.S. Physical Therapy, Inc. Elects Nancy Ham to the Board of Directors

Upcoming dividend of US$0.43 per share at 1.6% yield

U.S. Physical Therapy Declares Quarterly Dividend, Payable on June 9, 2023

First quarter 2023 earnings released: EPS: US$0.57 (vs US$0.67 in 1Q 2022)

Independent Director recently sold €439k worth of stock

Executive VP recently sold €87k worth of stock

Upcoming dividend of US$0.43 per share at 1.7% yield

Full year 2022 earnings released: EPS: US$2.25 (vs US$2.42 in FY 2021)

U.S. Physical Therapy, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Independent Director recently sold €573k worth of stock

President recently sold €858k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice from practice’s owners for $25 million.

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice for $25 million.

Insufficient new directors

Upcoming dividend of US$0.41 per share

Chief Operating Officer - West recently sold €162k worth of stock

Now 23% undervalued after recent price drop

Third quarter 2022 earnings released: EPS: US$0.73 (vs US$0.66 in 3Q 2021)

U.S. Physical Therapy, Inc. Provides Operating Guidance for 2022

U.S. Physical Therapy, Inc. (NYSE : USPH) acquired 60% stake in Fourteen-clinic physical therapy practice for $19.3 million.

U.S. Physical Therapy, Inc. to Report Q3, 2022 Results on Nov 03, 2022

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Two-Clinic Physical Therapy Practice for $4.2 million.

Director recently bought €78k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in six-clinic physical therapy practice in West Virginia and Pennsylvania for $3.5 million.

Independent Director recently bought €82k worth of stock